Evidence map›Paper›PMID 38719365›Full record

ArticleJournal of the American College of Cardiology2024

Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies.

Matteo Castrichini, Antonio De Luca, Giulia De Angelis, Raquel Neves, Alessia Paldino, Matteo Dal Ferro, Giulia Barbati, Kristen Medo, Andrea Barison, Chrysanthos Grigoratos and 21 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Journal of the American College of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07351838 (Prognosis and Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07351838 recruitingnot on this map

Prognosis and Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy : Cardiac MRI Insights for Better Outcomes

TypeobservationalSponsorChinese Academy of Medical Sciences, Fuwai HospitalRan2010 to 2030Enrolled1,000ConditionsNon-ischemic CardiomyopathyArmsNo intervention, Observational study
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  2. Review
  3. Article
  4. Classification of cardiomyopathies: bringing order to complexity.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. What Should a Clinical Cardiologist Know About Cardiogenetics?Journal of the American Heart Association · 2025
    Review
  11. Article
  12. Review
  13. Observational
  14. Review
  15. Review
  16. A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy.The international journal of cardiovascular imaging · 2025
    Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Matteo CastrichiniCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart); Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; University of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Antonio De LucaCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Giulia De AngelisCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Raquel NevesDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Alessia PaldinoCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Matteo Dal FerroCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Giulia BarbatiBiostatistics Unit, Department of Medical Sciences, University of Trieste, Trieste, Italy.
Kristen MedoUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Andrea BarisonFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Chrysanthos GrigoratosFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Marta GigliCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Davide StolfoCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart); Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Francesca BrunCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Daniel W GrovesUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Robert QuaifeUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Ramone EldemireUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Sharon GrawUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Jeffrey AddisonUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Giancarlo TodiereFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Ignazio Alessio GueliFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Nicoletta BottoFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Michele EmdinFondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy; Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Giovanni Donato AquaroAcademic Radiology Unit, Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Ramin GarmanyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Naveen L PereiraDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Matthew R G TaylorUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
Michael J AckermanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Gianfranco SinagraCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart).
Luisa MestroniUniversity of Colorado Cardiovascular Institute, Anschutz Medical Campus, Aurora, Colorado, USA.
John R GiudicessiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Marco MerloCardiothoracovascular Department, Division of Cardiology, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy, member of European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart). Electronic address: marco.merlo@asugi.sanita.fvg.it.

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences Institute (CCTSI)UM1TR004399 · NCATS · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS, RONALD J. SOKOL · 2023 to 2026
$30.7M
Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic CardiomyopathyR01HL116906 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI MARCUS, FRANK I, MESTRONI, LUISA · 2013 to 2016
$9.2M
Engineering Cardiac spheroids to study LaminopathiesR01HL164634 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Luisa Mestroni, Matthew R Taylor · 2023 to 2026
$2.8M
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyR01HL147064 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA, TAYLOR, MATTHEW R · 2020 to 2023
$2.1M
NCATS NIH HHS UL1 TR002535NCATS NIH HHS UM1 TR004399NHLBI NIH HHS R01 HL116906NHLBI NIH HHS R01 HL147064NHLBI NIH HHS R01 HL164634
6 · The paper itself

Abstract

backgroundNondilated left ventricular cardiomyopathy (NDLVC) has been recently differentiated from dilated cardiomyopathy (DCM). A comprehensive characterization of these 2 entities using cardiac magnetic resonance (CMR) and genetic testing has never been performed.

objectivesThis study sought to provide a thorough characterization and assess clinical outcomes in a large multicenter cohort of patients with DCM and NDLVC.

methodsA total of 462 patients with DCM (227) or NDLVC (235) with CMR data from 4 different referral centers were retrospectively analyzed. The study endpoint was a composite of sudden cardiac death or major ventricular arrhythmias.

resultsIn comparison to DCM, NDLVC had a higher prevalence of pathogenic or likely pathogenic variants of arrhythmogenic genes (40% vs 23%; P < 0.001), higher left ventricular (LV) systolic function (LV ejection fraction: 51% ± 12% vs 36% ± 15%; P < 0.001) and higher prevalence of free-wall late gadolinium enhancement (LGE) (27% vs 14%; P < 0.001). Conversely, DCM showed higher prevalence of pathogenic or likely pathogenic variants of nonarrhythmogenic genes (23% vs 12%; P = 0.002) and septal LGE (45% vs 32%; P = 0.004). Over a median follow-up of 81 months (Q1-Q3: 40-132 months), the study outcome occurred in 98 (21%) patients. LGE with septal location (HR: 1.929; 95% CI: 1.033-3.601; P = 0.039) was independently associated with the risk of sudden cardiac death or major ventricular arrhythmias together with LV dilatation, older age, advanced NYHA functional class, frequent ventricular ectopic activity, and nonsustained ventricular tachycardia.

conclusionsIn a multicenter cohort of patients with DCM and NDLVC, septal LGE together with LV dilatation, age, advanced disease, and frequent and repetitive ventricular arrhythmias were powerful predictors of major arrhythmic events.

Indexed as

Cardiomyopathy, DilatedMagnetic Resonance Imaging, CineAdultAgedDeath, Sudden, CardiacFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective Studiesarrhythmiasdilated cardiomyopathyLGEnondilated left ventricular cardiomyopathySCD

Identifiers

PMID38719365
PMCPMC12042165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.